Tiger Seed Hound Partners Dumps its Valeant Shares

August 09, 2016   Stephen Taub


The firm told investors it’s given up on the troubled drug maker, which has badly hurt its funds in 2016, and has embarked on a “period of introspection” over its performance.

Jonathan Auerbach’s Hound Partners has finally thrown in the towel on Valeant Pharmaceuticals International, a stock that boosted the firm’s coffers spectacularly in recent years before tanking its portfolio over the past ten months. The New York-based firm — a …

Subscribe

Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.

Subscribe now

Free trial

Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.

Free Trial




Latest Poll

How will hedge funds finish 2017?

 - 73%
 - 11%
 - 16%

View previous results